Direct-so-consumer marketing of prescription drugs. Creating consumer demand

JAMA

Volumn 281, Issue 4, 1999, Pages 382-384

  Hollon, Matthew F ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; CONSUMER; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033608127     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.4.382     Document Type: Short Survey

References (32)

1. Food and Drug Administration. Direct-to-consumer advertising of prescription drugs: withdrawal of moratorium. Federal Register. September 9,1985;50:36677-36678.
2. Cohen EP. Direct-to-the-public advertisement of prescription drugs. N Engl J Med. 1988;318:373-376.
3. US Department of Health and Human Services, Public Health Service, Food and Drug Administration. FDA to review standards for all direct-to-consumer Rx drug promotion. Available at: http://www.fda.gov/bbs/topics/NEWS/NEW00582.html. Accessed August 25, 1997.
4. Weber J, Carey J. Drug ads: a prescription for controversy Business Week. January 18, 1993:58-59.
5. Freeman L. Aggressive strategy helps propel Claritin to top slot. Advertising Age. March 16, 1998;69(11):S6-S7.
6. Liebman H. Consumer, heal thyself: ads for prescription drugs are popping up more frequently in consumer media. Mediaweek. July 5, 1993;3(27):12.
7. Wilke M. Prescription for profit. Advertising Age. March 16, 1998;69(11):S1, S26
8. Why do Americans resist a healthy lifestyle? USA Today Magazine. October 1994;123(2593):1-2.
9. Harper J. Information overload may be making some Americans sick. Insight on the News. September 15, 1997;13(34):40-41.
10. Peck CC, Rheinstein PH. FDA regulation of prescription drug advertising. JAMA 1990;264:2424-2425.
11. Wade VA, Mansfield PR, McDonald PJ. Drug companies' evidence to justify advertising. Lancet. 1989;2:1261-1264.
12. Herxheimer A, Lundborg CS, Westerholm B. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards, Int J Health Serv. 1993;23:161-172.
13. Stryer D. Bero LA. Characteristics of materials distributed by drug companies. J Gen Intern Med. 1996;11:575-583.
14. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116:912-919.
15. Drug advertising: is this good medicine? Consumer Reports. June 1996;61 (6):62-63.
16. Kessler DA. Addressing the problem of misleading advertising. Ann Intern Med. 1992;116:950-951.
17. Williams RJ, Heymann DL. Containment of antibiotic resistance. Science. 1998; 279:1153-1154.
18. Low DE, Scheld WM. Strategies for stemming the tide of antimicrobial resistance. JAMA. 1998;279:394-395.
19. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581-588.
20. Gerber P. Mass product-liability litigation. Med J Aust. 1988;148:485-488.
21. US Department of Health and Human Services, Public Health Service, Food and Drug Administration. FDA public hearing: direct-to-consumer promotion. Available at: http://www2.evolvingtech.com/etc/industry/hearings/ 95N227contents.html. Accessed June 21, 1997.
22. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? JAMA. 1997;278:1745-1748.
23. Hemminki E. Review of literature on the factors affecting drug prescribing. Soc Sci Med. 1975;9:111-115.
24. Weiss MC, Fitzpatrick R, Scott DK, Goldacre MJ. Pressures on the general practitioner and decisions to prescribe. Fam Pract. 1996;13:432-438.
25. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientific drug prescribing. Soc Sci Med. 1989;28:577-582.
26. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract. 1996;43:56-62.
27. Greenhalgh T, Gill P. Pressure to prescribe. BMJ. 1997;315:1482-1483.
28. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272:292-296.
29. Hueston WJ, Mainous AG III, Brauer N. Mercuri J. Evaluation and treatment of respiratory infections: does managed care make a difference? J Fam Pract. 1997; 44:572-577.
30. National Consumers League, Golodner LF. Consumer group responds to FDA's draft guidance on direct-to-consumer advertising on television. Available at: http:// www.natlconsumersleague.org/dtcp.htm. Accessed August 26, 1997.
31. Whyte J Direct consumer advertising of prescription drugs. JAMA 1993;269: 146, 150.
32. Wilke M, Teinowitz I, Kelly KJ. Ad fever sweeps healthcare industry. Advertising Age. January 13, 1997;68(2):1, 18-19.